Surface marker expression is of particular interest due to its potential applications in both cancer diagnostics and targeted therapy; therefore, we next analyzed whether the knockout of CD133 or its epigenetic regulator TRIM28 affects the membrane proteome of Caco2 cells. This evidence concerns the gene PROM1 and cancer.